연구동향 분석

Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study

전가원 오민경 신종범 2015년

논문상세정보
인용/피인용
' Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • beractant
  • calfactant
  • poractant alfa
  • pulmonary surfactants
  • respiratory distress syndrome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,609 0

0.0%

' Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study' 의 참고문헌

  • Tarnow-Mordi W; UK Neonatal Staffing Study Collaborative Group. CRIB II: an update of the clinical risk index for babies score
    Parry G Lancet 361 : 1789 ~ 1791 [2003]
  • Tarnow-Mordi W; UK Neonatal Staffing Study Collaborative Group. CRIB II: an update of the clinical risk index for babies score
    Parry G Lancet 361 1789-1791 [2003]
  • Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials
    Moya F J Perinatol 29 (Suppl 2) : S23 ~ S28 [2009]
  • Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials
    Moya F J Perinatol 29 Suppl 2 S23-S28 [2009]
  • Surfactant-replacement therapy for respiratory distress in the preterm and term neonate
    Engle WA Pediatrics 121 : 419 ~ 432 [2008]
  • Surfactant-replacement therapy for respiratory distress in the preterm and term neonate
    Engle WA Pediatrics 121 419-432 [2008]
  • Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology
    Jobe A Adv Pediatr 30 : 93 ~ 130 [1983]
  • Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology
    Jobe A Adv Pediatr 30 93-130 [1983]
  • Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often
    Rüdiger M Crit Care Med 28 : 1572 ~ 1577 [2000]
  • Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often
    Rüdiger M Crit Care Med 28 1572-1577 [2000]
  • One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials
    Moya F Pediatrics 19 : e1361 ~ e1370 [2007]
  • One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials
    Moya F Pediatrics 19 e1361-e1370 [2007]
  • Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection
    Stoll BJ JAMA 292 : 2357 ~ 2365 [2004]
  • Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection
    Stoll BJ JAMA 292 2357-2365 [2004]
  • Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network
    Stoll BJ Pediatrics 126 : 443 ~ 456 [2010]
  • Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network
    Stoll BJ Pediatrics 126 443-456 [2010]
  • Necrotizing enterocolitis: treatment based on staging criteria
    Walsh MC Pediatr Clin North Am 33 : 179 ~ 201 [1986]
  • Necrotizing enterocolitis: treatment based on staging criteria
    Walsh MC Pediatr Clin North Am 33 179-201 [1986]
  • Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
    Soll RF Cochrane Database Syst Rev : CD000144 ~ [2001]
  • Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
    Soll RF Cochrane Database Syst Rev CD000144- [2001]
  • Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
    Ramanathan R J Perinatol 33 : 119 ~ 125 [2013]
  • Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study
    Ramanathan R J Perinatol 33 119-125 [2013]
  • Intrauterine growth as estimated from Liveborn birth-weight data at 24 to 42 weeks of gestation
    Lubchenco LO Pediatrics 32 : 793 ~ 800 [1963]
  • Intrauterine growth as estimated from Liveborn birth-weight data at 24 to 42 weeks of gestation
    Lubchenco LO Pediatrics 32 793-800 [1963]
  • Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm
    Papile LA J Pediatr 92 : 529 ~ 534 [1978]
  • Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm
    Papile LA J Pediatr 92 529-534 [1978]
  • History of surfactant up to 1980
    Obladen M. Biol Neonate 87 : 308 ~ 316 [2005]
  • History of surfactant up to 1980
    Obladen M. Biol Neonate 87 308-316 [2005]
  • History of surfactant from 1980
    Halliday HL Biol Neonate 87 : 317 ~ 322 [2005]
  • History of surfactant from 1980
    Halliday HL Biol Neonate 87 317-322 [2005]
  • Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis
    Singh N Pediatrics 128 : e1588 ~ e1595
  • Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis
    Singh N Pediatrics 128 e1588-e1595 [2011]
  • Comparative effectiveness of surfactant preparations in premature infants
    Trembath A J Pediatr 163 : 955 ~ 960 [2013]
  • Comparative effectiveness of surfactant preparations in premature infants
    Trembath A J Pediatr 163 955-960 [2013]
  • Bronchopulmonary dysplasia
    Kinsella JP Lancet 367 : 1421 ~ 1431 [2006]
  • Bronchopulmonary dysplasia
    Kinsella JP Lancet 367 1421-1431 [2006]
  • Artificial surfactant therapy in hyaline-membrane disease
    Fujiwara T Lancet 1 : 55 ~ 59 [1980]
  • Artificial surfactant therapy in hyaline-membrane disease
    Fujiwara T Lancet 1 55-59 [1980]
  • Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials
    Ramanathan R J Perinatol 29 (Suppl 2) : S38 ~ S43 [2009]
  • Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials
    Ramanathan R J Perinatol 29 Suppl 2 S38-S43 [2009]
  • Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
    Logan JW Ther Clin Risk Manag 5 : 251 ~ 260 [2009]
  • Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
    Logan JW Ther Clin Risk Manag 5 251-260 [2009]
  • An international classification of retinopathy of prematurity
    Pediatrics 74 : 127 ~ 133 [1984]
  • An international classification of retinopathy of prematurity
    Pediatrics 74 127-133 [1984]
  • A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants
    Moya FR Pediatrics 115 : 1018 ~ 1029 [2005]
  • A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants
    Moya FR Pediatrics 115 1018-1029 [2005]
  • 50 Years ago in The Journal of Pediatrics: Respiratory distress syndrome of newborn infants: I. Diagnosis and incidence Miller H. J Pediatr 1962;61:2-8. Respiratory Distress Syndrome of Newborn Infants: II. Clinical Study of Pathogenesis Miller H
    Jobe AH J Pediatr 161 : 93 ~ [2012]
  • 50 Years ago in The Journal of Pediatrics: Respiratory distress syndrome of newborn infants: I. Diagnosis and incidence Miller H. J Pediatr 1962;61:2-8. Respiratory Distress Syndrome of Newborn Infants: II. Clinical Study of Pathogenesis Miller H
    Jobe AH J Pediatr 161 93- [2012]